stella
beta
A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP — Stella
Recruiting
Back to Congenital Erythropoietic Porphyria (CEP) trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(1 site)
United States
The Cleveland Clinics, Cleveland, Ohio
View full record on ClinicalTrials.gov